RedHill Biopharma (Israel) Financial Indicators Patterns

RDHL -- Israel Stock  

ILS 308.40  12.00  4.05%

We recommend you to use RedHill Biopharma fundamental analysis to see if markets are presently mispricing the firm. In other words this interface allows you to confirm available drivers of RedHill Biopharma as well as the relationship between them. . We found twenty-six available financial ratios for RedHill Biopharma which can be compared to its competitors. To make sure the equity is not overpriced, please check all RedHill Biopharma fundamentals including its Shares Outstanding, Revenue, EBITDA, as well as the relationship between Price to Sales and Gross Profit . Use RedHill Biopharma to enhance returns of your portfolios. The stock experiences very speculative upward sentiment.. Check odds of RedHill Biopharma to be traded at S385.5 in 30 days

RedHill Biopharma Company Summary

RedHill Biopharma competes with Bezeq Israel, Oil Refineries, Perrigo Company, Bank Leumi, and Israel Chemicals. RedHill Biopharma Ltd., a specialty biopharmaceutical company, focuses on the development and commercialization of late clinical-stage drugs for the treatment of gastrointestinal diseases. The company was founded in 2009 and is headquartered in Tel Aviv, Israel. RedHill Biopharma operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange. It employs 74 people.

RedHill Biopharma Current Liabilities vs Retained Earnings

RedHill Biopharma Ltd is rated below average in current liabilities category among related companies. It is rated below average in retained earnings category among related companies .

RedHill Biopharma Market Fundamentals

 Change(%) 4.05%

Distress Rating

RedHill Biopharma Financial Distress Probability

Chance of Financial Distress
RedHill Biopharma Ltd has less than 40 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare RedHill Biopharma

Compare RedHill Biopharma To Peers

RedHill Biopharma Opportunity Range

October 21, 2018 Opportunity Range

Additionally take a look at Your Equity Center. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.